The effect of polyamine homologation on the transport and cytotoxicity properties of polyamine-(DNA-intercalator) conjugates

Journal of Organic Chemistry

Volumn 65, Issue 18, 2000, Pages 5590-5599

  Phanstiel IV, Otto ^a   Price, Harry L ^a   Wang, Lu ^a   Juusola, Jane ^a   Kline, Martin ^a   Shah, Sapna Majmundar ^a  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE; ANTHRACENE; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); POLYAMINE; POLYAMINE DERIVATIVE; SPERMIDINE;

ANIMAL CELL; ARTICLE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CYTOTOXICITY; ENZYME INHIBITION; IC 50; KINETOPLAST; MOUSE; NONHUMAN;

ANIMALS; ANTINEOPLASTIC AGENTS; DNA TOPOISOMERASES, TYPE II; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INTERCALATING AGENTS; LEUKEMIA L1210; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICE; POLYAMINES; TUMOR CELLS, CULTURED;

EID: 0033832989     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0002792     Document Type: Article

References (46)

1. Morgan, D. M. Biochem. Soc. Transactions 1990, 18, 1080-1084.
2. Zwelling, L. A.; Michaels, S.; Erickson, L. C.; Ungerleider, R. S.; Nichols, M.; Kohn, K. W. Biochemistry, 1981, 20, 6553-6563.
3. Zwelling, L. A.; Kerrigan, D.; Micheals, S. Cancer Res. 1982, 42, 2687-2691.
4. Pommier, Y.; Kerrigan, D.; Schwartz, R.; Zwelling, L. A. Biochem. Biophys. Res. Commun. 1982, 77, 1150-1157.
5. Nelson, E. M.; Tewey, K. M.; Liu, L. F. Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 1361-1365.
6. Denstman, S. C.; Ervin, S. J.; Casero, R. A. Biochem. Biophys. Res. Commun. 1987, 149, No. 1, 194-202.
7. Albert, A. The Acridines, 2nd ed.; Edward Arnold: London, 1966.
8. Atwell, G. J.; Cain, B. F.; Baguley, B. C.; Finlay, G. J.; Denny, W. A. J. Med. Chem. 1984, 27, 1481-1485.
9. Ghaneolhosseini, H.; Tjarks, W.; Sjoberg, S. Tetrahedron 1998, 54, 3877-3884.
10. Kumar, C. V.; Asuncion, E. H. J. Am. Chem. Soc. 1993, 115, 8547-8553.
11. Atwell, G. J.; Cain, B. F.; Denny, W. A. J. Med. Chem. 1977, 20, 1128-1134.
12. Cohen, G. M.; Cullis, P.; Hartley, J. A.; Mather, A.; Symons, M. C. R.; Wheelhouse, R. T. J. Chem. Soc., Chem. Commun. 1992, 298-300.
13. Holley J. L.; Mather, A.; Wheelhouse, R. T.; Cullis, P. M.; Hartley, J. A.; Bingham J. P.; Cohen, G. M. Cancer Res. 1992, 52, 4190-4195.
14. Blagbrough, I. S.; Geall, A. J. Tetrahedron Lett. 1998, 439-442.
15. Blagbrough, I. S.; Taylor, S.; Carpenter, M. L.; Novoselskiy, V.; Shamma, T.; Haworth, I. S. Chem. Commun. 1998, 929-930.
16. Fenniri, H.; Hosseini, M. W.; Lehn, J.-M. Helv. Chim. Acta 1997, 80, 786-803.
17. Haensler, J.; Szoka, F. C., Jr. Bioconjugate Chem. 1993, 4, 85-93.
18. Rodger, A.; Taylor, S.; Adlam, G.; Blagbrough, I. S.; Haworth, I. S. Bioorg. Med. Chem. 1995, 3(6), 861-872.
19. Geall, A. J.; Blagbrough, I. S. Tetrahedron Lett. 1998, 39, 443-446.
20. Cain, B. F.; Seelye, R. N.; Atwell, G. J. J. Med. Chem. 1974, 17, 922-930.
21. Atwell, G. J.; Cain, B. F. J. Med. Chem. 1974, 17, 930-934.
22. Cain, B. F.; Baguley, B. C.; Denny, W. A. J. Med. Chem. 1978, 21, 658-668.
23. Porter, C. W.; Bergeron, R. J.; Stolowich, N. J. Cancer Res. 1982, 42, 2, 4072-4078.
24. Lurdes, M.; Almeida, S.; Grehn, L.; Ragnarsson, U. J. Chem. Soc., Chem. Commun. 1987, 1250-1251.
25. Lurdes, M.; Almeida, S.; Grehn, L.; Ragnarsson, U. J. Chem. Soc., Perkin Trans. 1 1988, 1905-1911.
26. (a) Dupre, D. J.; Robinson, F. A. J. Chem. Soc. 1945, 549-551.
27. (b) For an alternative method using 9-(1,2,4-triazole) intermediates, see: Carlson, C. B.; Beal, P. A. Org. Lett. 2000, 2(10), 1465-1468.
28. Kohn, K. W.; Orr, A.; O'Connor, P. M.; Guziec, L. J.; Guziec, F. S., Jr. J. Med. Chem. 1994, 37, 67-72 and references therein.
29. Adamczyk, M.; Fishpaugh, J. R.; Heuser, K. J. Org. Prep. Proc. Int. 1998, 30, 339-348.
30. Shapiro, T. A.; Klein, V. A.; Englund, P. T. J. Biol. Chem. 1989, 264, 4173-4178.
31. kDNA and TOPO-II assay kits can be purchased from TopoGEN, Inc.
32. Muller, M. T.; Helal, K.; Soisson, S.; Spitzner, J. R. Nucl. Acid Res. 1989, 17, 9499.
33. Zwelling, L. A.; Hinds, M.; Chan, D.; Mayes, J.; Sie, K. L.; Parker, E.; Silberman, L.; Radcliffe, A.; Beran, M.; Blick, M. J. Biol. Chem. 1989, 264, 16411-16420.
34. Pearl, L. H.; Skelly, J. V.; Hudson, B. D.; Neidle, S. Nucl. Acids Res. 1987, 15, 3469-3477.
35. Yoshida, M.; Banville, D. L.; Shafer, R. H. Biochemistry, 1990, 29, 6585-6592.
36. Denny, W. Anti-Cancer Drug Des. 1989, 4, 241-263.
37. Zegar, I. S.; Prakash, A. S.; Harvey, R. G.; LeBreton, P. R. J. Am. Chem. Soc. 1985, 107, 7990-7995.
38. (a) Price, H. L.; Phanstiel, O., IV. Unpublished results.
39. (b) Stanslas, J.; Hagan, D. J.; Ellis, M. J.; Turner, C.; Carmichael, J.; Ward, W.; Hammonds, T. R.; Stevens, F. G. J. Med. Chem. 2000, 43, 1563-1572.
40. Bergeron, R. J.; Feng, Y.; Weimar, W. R.; McManis, J. S.; Dimova, H.; Porter, C.; Raisler, B.; Phanstiel, O. J. Med. Chem. 1997, 40, 1475-1494.
41. Kenakin, T. P. Pharmacologic Analysis of Drug-Receptor Interaction, 2nd ed.; Raven Press: New York, 1993; and references therein.
42. Kenakin, T. P.; Leighton, H. J. In Methods in Pharmacology. Methods Used in Adenosine Research; Paton, D. M., Ed.; Plenum Press: New York, 1984; Vol. 6, pp 213-237.
43. Kenakin, T. P. J. Pharmacol. Exp. Ther. 1982, 222, 752-758.
44. 2 =H) showed essentially no spermidine protection, unpublished work.
45. Malich, G.; Markovic, B.; Winder, C. Toxicology 1997, 124, 179-192.
46. Buttke, T. M.; McCubrey, J. A.; Owen, T. C. J. Immunol. Methods 1993, 157, 233-240.